Skip to main content
Clinical Trials/CTRI/2024/12/078610
CTRI/2024/12/078610
Not yet recruiting
Phase 3

comparison between blood flow restriction training and mulligan mobilization with movement in the management of lateral epicondylitis

Vidhi Joshi1 site in 1 country61 target enrollmentStarted: January 20, 2025Last updated:

Overview

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Vidhi Joshi
Enrollment
61
Locations
1
Primary Endpoint
Grip strength measurement, Pain intensity, and functional disability

Overview

Brief Summary

Aims & Objectives –

Aim: To evaluate the relative benefits of blood flow restriction training and mulligan mobilization with movement for alleviating pain, improving grip strength and functional disability in lateral epicondylitis patients.

Objectives- To assess the difference in grip strength between lateral epicondylitis patients receiving blood flow restriction training and those receiving mulligan mobilization with movement.

-To assess the impact of mulligan mobilization with movement and blood flow restriction training on the degree of pain and functional disability in lateral epicondylitis patients and comparison between both.

Hypothesis –

Null hypothesis-Blood flow restriction training and mulligan mobilization with movement will not significantly vary in terms of improving grip strength, reducing pain, or improving functional outcomes in individuals with lateral epicondylitis.

Alternate hypothesis- Blood flow restriction training and mulligan mobilization with movement will differ significantly in terms of improving grip strength, reducing pain, and improving functional outcomes in patients with lateral epicondylitis.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
Participant Blinded

Eligibility Criteria

Ages
20.00 Year(s) to 50.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Presence of pain on the lateral epicondyle of the elbow.
  • Tenderness on palpation on the lateral epicondyle.
  • Complaints persisting for at least 8 weeks.
  • There is an apparent decline in grip strength in the affected arm.
  • Informed consent form signed by participants.

Exclusion Criteria

  • Participants who had a history of surgery on the affected arm.
  • Participants with other upper extremity conditions (e.g. Carpal tunnel syndrome, rotator cuff pathology, biceps tear) that could interfere with the assessment of grip strength and function.
  • Participants who had received the corticosteroid injection around the affected elbow within the past 3 months.
  • Participants with systemic conditions, that may affect the healing or muscle performance (e.g. diabetes, rheumatoid arthritis, chronic inflammatory conditions, and hypertension both controlled and uncontrolled).
  • Participants on blood thinners or anticoagulant therapy, as BFR training could increase the risk of complications.
  • Pregnant women will be excluded due to potential risks associated with BFR training.
  • Participants who will experience significant discomfort, pain, or any other adverse reactions during a trial session of BFR training.
  • Participants with mental or cognitive impairments that could prevent them from understanding the study procedure or following the exercise protocol.

Outcomes

Primary Outcomes

Grip strength measurement, Pain intensity, and functional disability

Time Frame: Baseline, 4th and 6th weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Vidhi Joshi
Sponsor Class
Other [Self ]
Responsible Party
Principal Investigator
Principal Investigator

Vidhi Joshi

Amity Institute of Health Allied Sciences

Study Sites (1)

Loading locations...

Similar Trials